Parents' perspectives of non‐informative germline genetic testing in children with Juvenile Polyposis Syndrome
- 17 November 2025
- journal article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 34 (6) , e70140
Abstract
Juvenile Polyposis Syndrome (JPS) is a hereditary gastrointestinal polyposis condition characterized by the development of multiple juvenile‐type hamartomatous polyps. Approximately half of individuals meeting clinical diagnostic criteria for JPS have an identifiable germline pathogenic variant in SMAD4 or BMPR1A , while the remaining individuals have non‐informative genetic results. For pediatric cases, the proportion of children with an identifiable causative variant is likely much lower, with one study noting only 22% of pediatric patients having informative genetic testing. This qualitative study utilized surveys and interviews to explore the impact of non‐informative germline genetic results for JPS on parents' understanding of their child's diagnosis and prognosis, as well as recurrence risk and familial screening uptake. Coding reliability thematic analysis of transcripts was completed through open inductive coding. Common parental experiences emerging from interviews with eight parents of seven children with JPS included emotional turmoil throughout the diagnostic process, prognostic unpredictability, and limited familial screening uptake. While the majority of participants ( n = 7/8, 87.5%) correctly recalled their child's genetic testing results, those that did not receive genetic counseling ( n = 3/8, 37.5%) described feeling confused and uninformed in the pre‐ and post‐test setting. A majority of participants ( n = 6/8, 75%) questioned the permanence, natural history, and severity of their child's JPS, while those with more time to cope felt greater clarity and less concern. Such parental perceptions were noted to be heavily influenced by differences in polyp burden over time, genetic testing results, and initial acceptance of the clinical diagnosis. The desire for a genetic diagnosis to increase clarity in their child's long‐term management recommendations was noted by some participants ( n = 2/8, 25%). Our findings highlight the importance of timely and clear education surrounding prognosis, early incorporation of a genetic counselor in the diagnostic process, and providing follow‐up appointments to address misconceptions and resolve uncertainty.Keywords
This publication has 18 references indexed in Scilit:
- Research methodologies in genetic counseling: Grounded theoryJournal of Genetic Counseling, 2025
- Conceptual and design thinking for thematic analysis.Qualitative Psychology, 2022
- After genomic testing results: Parents’ long‐term viewsJournal of Genetic Counseling, 2021
- What improves the likelihood of people receiving genetic test results communicating to their families about genetic risk?Patient Education and Counseling, 2021
- Adult patients with undiagnosed conditions and their responses to unresolved uncertainty from exome sequencingJournal of Genetic Counseling, 2020
- The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancerJournal of Genetic Counseling, 2020
- Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probandsJournal of Genetic Counseling, 2019
- Caregivers' perception of and experience with variants of uncertain significance from whole exome sequencing for children with undiagnosed conditionsJournal of Genetic Counseling, 2019
- “It wasn't a disaster or anything”: Parents’ experiences of their child's uncertain chromosomal microarray resultAmerican Journal of Medical Genetics Part A, 2016
- Patient hopes for diagnostic genomic sequencing: roles of uncertainty and social statusEuropean Journal of Human Genetics, 2015